Tag Archives: ARRY

Hot Casino Stocks To Watch For 2019

Monday was a mixed day on Wall Street, as gains for major benchmarks contrasted with a decline in indexes tracking smaller companies. Many market participants focused on the White House’s support of Chinese mobile device maker ZTE, which lifted several of the biggest stocks of Chinese technology giants that trade on U.S. exchanges. In general, investors seem to be pleased with the health of the global economy, and absent reasons to the contrary, the path of least resistance appears to be a bounce from the recent correction. Some individual companies received especially good news that lifted shares today. Caesars Entertainment (NASDAQ:CZR), NXP Semiconductor (NASDAQ:NXPI), and Symantec (NASDAQ:SYMC) were among the best performers on the day. Here’s why they did so well.

Caesars gets some help from the Supreme Court

Shares of Caesars Entertainment rose 5% in the wake of good news for the casino industry from the U.S. Supreme Court. The nation’s highest court ruled that a more than 25-year-old federal law that had prevented nearly every state other than Nevada from allowing sports-related betting was unconstitutional, opening the door for Caesars and its peers to begin such operations if state legislatures pass laws allowing sports betting. New Jersey, which was the state seeking to have the law declared unconstitutional, appears ready to move quickly, and Caesars praised the decision. The company said it will need to take time to understand the consequences of the legal win before offering specific strategy, but investors think it’ll be a big win for Caesars to be able to have sports betting throughout its network rather than only in its Nevada locations.

Hot Casino Stocks To Watch For 2019: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By Steve Symington]

    2U Inc. (NASDAQ:TWOU) announced better-than-expected second-quarter 2018 results late Thursday, detailing a particularly busy quarter for new domestic graduate-program announcements. 2U also increased its full-year financial guidance.

  • [By Steve Symington]

    Shares of 2U (NASDAQ:TWOU) climbed 17.8% in the month of May, according to data from S&P Global Market Intelligence, after the online education platform specialist delivered exceptional first-quarter 2018 results.

  • [By Todd Campbell]

    I’m always on the lookout for fast-growing stocks to include in my retirement portfolio. Recently, I bought shares in Paycom Software, Inc. (NYSE:PAYC), BioMarin Pharmaceutical (NASDAQ:BMRN), and 2U Inc. (NASDAQ:TWOU). Are these stocks right for your portfolio, too? Read on to learn why I think these companies can deliver market-beating returns.

  • [By Steve Symington]

    2U Inc. (NASDAQ:TWOU) announced first-quarter 2018 results on Thursday after the market closed, highlighting not only the strength of its core Graduate Program business, but also the growing influence of its short-course offerings following its acquisition of GetSmarter last year. Shares were up more than 6% on Friday as of this writing, so let’s settle in to learn more about what drove the online education-platform company this quarter, as well as what investors should be watching in the year ahead.

  • [By Steve Symington]

    Shares of 2U Inc. (NASDAQ:TWOU) fell 15.9% in September, according to data from S&P Global Market Intelligence, following an analyst’s note of caution on the online education platform specialist.

Hot Casino Stocks To Watch For 2019: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterday’s 18% pop. And your core holding XBI continues to rake in the gains.

  • [By George Budwell]

    Although Soros has ceded the day-to-day control of the fund to others, its quarterly activity is still worth following by any serious investor. Per the latest 13F filings, for example, the Soros Fund Management curiously decided to pick up $8.6 million worth of shares of the clinical-stage biotech Array BioPharma (NASDAQ:ARRY) during the second quarter of 2018. 

  • [By Ethan Ryder]

    Shares of Array Biopharma Inc (NASDAQ:ARRY) have received an average rating of “Buy” from the eleven research firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $23.57.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Hot Casino Stocks To Watch For 2019: AmeriGas Partners, L.P.(APU)

Advisors’ Opinion:

  • [By John Bromels]

    If you’re like me, you probably use branded propane tanks from AmeriGas Partners (NYSE:APU) or Blue Rhino, which is owned by Ferrellgas Partners, L.P. (NYSE:FGP) (Full disclosure: Propane is propane. I use AmeriGas because it’s what the local convenience store sells.) Either one will get your burgers cooked, but which one will keep your portfolio cooking along? 

  • [By Motley Fool Transcribers]

    Amerigas Partners LP  (NYSE:APU)Q1 2019 Earnings Conference CallFeb. 06, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Maxx Chatsko]

    Investors seeking income from energy stocks will find it difficult to match the impressive yields of Ferrellgas Partners LP (NYSE:FGP) and AmeriGas Partners (NYSE:APU), which sit at 11.9% and 9%, respectively. However, this is a textbook case of higher yields representing higher levels of risk.

  • [By John Bromels]

    I use propane tanks from AmeriGas Partners (NYSE:APU) because that’s what my local convenience store sells, but many outdoor cooks use Blue Rhino, which is owned by Ferrellgas Partners, L.P. (NYSE:FGP). There’s no difference between them when it comes to getting your burgers browned or your ribs crispy — propane is propane, after all, regardless of who’s selling it — but there are big differences in the two companies from an investor’s standpoint. 

Hot Casino Stocks To Watch For 2019: Advantest Corporation (Kabushiki Kaisha Advantest) ADS(ATE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Antibe Therapeutics Inc (CVE:ATE) Director Nicolas Bourgeois bought 100,000 shares of Antibe Therapeutics stock in a transaction on Tuesday, September 18th. The shares were acquired at an average price of C$0.26 per share, for a total transaction of C$26,000.00.

Hot Casino Stocks To Watch For 2019: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By Shane Hupp]

    First Eagle Investment Management LLC trimmed its holdings in shares of Tiffany & Co. (NYSE:TIF) by 0.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,798,751 shares of the specialty retailer’s stock after selling 29,056 shares during the period. First Eagle Investment Management LLC owned 3.06% of Tiffany & Co. worth $370,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Dan Caplinger]

    The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren’t happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve’s monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here’s why they did so well.

  • [By Joseph Griffin]

    Susquehanna Bancshares reiterated their neutral rating on shares of Tiffany & Co. (NYSE:TIF) in a research report report published on Thursday morning. They currently have a $100.00 target price on the specialty retailer’s stock.

  • [By Shane Hupp]

    Meag Munich Ergo Kapitalanlagegesellschaft MBH cut its holdings in shares of Tiffany & Co. (NYSE:TIF) by 16.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,085 shares of the specialty retailer’s stock after selling 2,836 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in Tiffany & Co. were worth $1,866,000 at the end of the most recent quarter.

Hot Casino Stocks To Watch For 2019: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Max Byerly]

    Press coverage about Tandy Leather Factory (NASDAQ:TLF) has trended somewhat positive on Sunday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tandy Leather Factory earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave press coverage about the textile maker an impact score of 48.0642054684382 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Shane Hupp]

    Tandy Leather Factory (NASDAQ: TLF) and Vera Bradley (NASDAQ:VRA) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Top Growth Stocks To Buy For 2019

Analysts expect Spirit Realty Capital Inc (NYSE:SRC) to post earnings per share (EPS) of $0.17 for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Spirit Realty Capital’s earnings, with estimates ranging from $0.16 to $0.18. Spirit Realty Capital reported earnings per share of $0.23 during the same quarter last year, which would indicate a negative year-over-year growth rate of 26.1%. The company is expected to issue its next quarterly earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Spirit Realty Capital will report full year earnings of $0.74 per share for the current financial year, with EPS estimates ranging from $0.70 to $0.77. For the next financial year, analysts expect that the business will post earnings of $0.68 per share, with EPS estimates ranging from $0.66 to $0.71. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Spirit Realty Capital.

Top Growth Stocks To Buy For 2019: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Del Taco Restaurants (NASDAQ:TACO) from a sell rating to a hold rating in a report issued on Thursday morning.

    Several other analysts also recently weighed in on the stock. ValuEngine raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Tuesday, June 5th. Zacks Investment Research raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Saturday, July 7th. Citigroup lifted their price target on shares of Del Taco Restaurants from $13.00 to $16.00 and gave the company a buy rating in a research note on Thursday, June 21st. TheStreet raised shares of Del Taco Restaurants from a c+ rating to a b- rating in a research note on Wednesday, July 18th. Finally, Dougherty & Co lifted their price target on shares of Del Taco Restaurants from $16.50 to $18.50 and gave the company a buy rating in a research note on Friday, July 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of Buy and an average target price of $16.06.

  • [By ]

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

    Snap (SNAP) : “I think this one is going nowhere.”

  • [By Stephan Byrd]

    Arcos Dorados (NYSE:ARCO) and Del Taco Restaurants (NASDAQ:TACO) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

  • [By Max Byerly]

    The analysts wrote, “We maintain our Buy rating and $19 price target on Del Taco (TACO) as the company’s 3Q18 (September) draws to a close. We lower our 3Q18 (September) EPS estimate to $0.15, from $0.16, though maintain our above-guidance $0.63 EPS estimate for 2018. Our EPS estimates of $0.72 for 2019 (vs. $0.67 consensus) and $0.79 for 2020 are unchanged. We believe recent M&A activity in the industry will push TACO’s valuation multiples higher.””

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Del Taco Restaurants (TACO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Del Taco Restaurants, Inc. (NASDAQ: TACO) shares saw a slight bump on Wednesday after one key analyst upped its price target on the taco chain. The upshot from this report is tasty returns for investors.

Top Growth Stocks To Buy For 2019: Odyssey Marine Exploration Inc.(OMEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News stories about Odyssey Marine Exploration (NASDAQ:OMEX) have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Odyssey Marine Exploration earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.3184749361846 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Max Byerly]

    Odyssey Marine Exploration (NASDAQ: OMEX) and Teekay Offshore Partners (NYSE:TOO) are both small-cap transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Joseph Griffin]

    Kenon (NYSE: KEN) and Odyssey Marine Exploration (NASDAQ:OMEX) are both small-cap utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Top Growth Stocks To Buy For 2019: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Array Biopharma Inc (NASDAQ:ARRY) traded down 7.2% on Friday . The company traded as low as $13.48 and last traded at $13.98. 4,906,836 shares changed hands during trading, an increase of 68% from the average session volume of 2,921,348 shares. The stock had previously closed at $15.06.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Array Biopharma (ARRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Shane Hupp]

    Eversept Partners LLC reduced its position in shares of Array Biopharma Inc (NASDAQ:ARRY) by 71.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 357,727 shares of the biopharmaceutical company’s stock after selling 880,076 shares during the period. Array Biopharma accounts for about 2.8% of Eversept Partners LLC’s holdings, making the stock its 13th biggest position. Eversept Partners LLC owned approximately 0.17% of Array Biopharma worth $5,838,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    Array Biopharma Inc (NASDAQ:ARRY)Q4 2018 Earnings Conference CallAug. 14, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterday’s 18% pop. And your core holding XBI continues to rake in the gains.

Best High Tech Stocks To Invest In Right Now

Netflix may have surged 110 percent so far this year, but World Wrestling Entertainment (WWE) has been giving the streaming giant a run for its money and market watchers believe the stock will continue to clean house.

Shares of WWE rallied 3 percent Friday as Morgan Stanley raised its price target on the stock to $100 from $58. As WWE was trading around $76 on Friday morning, this means that analysts are predicting another 30 percent upside for the name.

Oppenheimer technician Ari Wald is also bullish on WWE and believes the stock is about to soar even higher than the 152 percent it has already surged this year.

“This is a great example of momentum in markets,” he said Thursday on CNBC’s “Trading Nation.” “All of the academic research shows that stocks with high risk-adjusted returns over the previous year usually continue to be the leaders over the coming year, and we like momentum.”

Best High Tech Stocks To Invest In Right Now: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Array Biopharma (ARRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Array Biopharma Inc (NASDAQ:ARRY) traded down 7.2% on Friday . The company traded as low as $13.48 and last traded at $13.98. 4,906,836 shares changed hands during trading, an increase of 68% from the average session volume of 2,921,348 shares. The stock had previously closed at $15.06.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Array Biopharma (ARRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Shares of Array Biopharma Inc (NASDAQ:ARRY) have received an average rating of “Buy” from the eleven research firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $23.57.

  • [By Motley Fool Transcribers]

    Array Biopharma Inc (NASDAQ:ARRY)Q4 2018 Earnings Conference CallAug. 14, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Array Biopharma Inc (NASDAQ:ARRY) CEO Ron Squarer sold 184,253 shares of the stock in a transaction that occurred on Wednesday, June 27th. The shares were sold at an average price of $17.96, for a total transaction of $3,309,183.88. Following the completion of the transaction, the chief executive officer now owns 289,456 shares of the company’s stock, valued at $5,198,629.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Best High Tech Stocks To Invest In Right Now: TeleNav Inc.(TNAV)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Telenav (NASDAQ:TNAV) from a sell rating to a hold rating in a research note published on Saturday.

    Several other equities research analysts also recently issued reports on TNAV. BidaskClub upgraded Telenav from a sell rating to a hold rating in a report on Friday. Zacks Investment Research upgraded Telenav from a sell rating to a hold rating in a report on Thursday, April 5th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $11.17.

  • [By Stephan Byrd]

    Telenav Inc (NASDAQ:TNAV) has received a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $11.17.

Best High Tech Stocks To Invest In Right Now: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Approach Resources Inc. (NASDAQ:AREX) hit a new 52-week low during trading on Thursday . The company traded as low as $2.02 and last traded at $2.04, with a volume of 2875 shares trading hands. The stock had previously closed at $2.08.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Media headlines about Approach Resources (NASDAQ:AREX) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Approach Resources earned a coverage optimism score of 0.02 on Accern’s scale. Accern also gave press coverage about the energy company an impact score of 46.8987147373518 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Best High Tech Stocks To Invest In Right Now: Eaton Vance Limited Duration Income Fund(EVV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance Ltd Duration Income Fund (NYSEAMERICAN:EVV) was the recipient of a large increase in short interest in September. As of September 14th, there was short interest totalling 61,700 shares, an increase of 154.4% from the August 31st total of 24,249 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 199,358 shares, the short-interest ratio is currently 0.3 days.

Best High Tech Stocks To Invest In Right Now: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    McKesson (NYSE:MCK) Q3 2019 Earnings Conference CallJan. 31, 2019 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    Robbins made the comment during his presentation at the Sohn conference, adding that he was refuting speculation that he was opposed to the deal. Glenveiw Capital owns a 1.2% of Cigna, according to FactSet. Robbins added that he likes Express Scripts, CVS (CVS) and McKesson Corp. (MCK) .

  • [By ]

    It may be unhealthy to trade drug stocks Friday. The word on Wall Street is to not expect too much from President Trump’s speech on drug prices. That means expect the unexpected, and prepare for a volatility spike in key healthcare names such as Express Scripts (ESRX) , CVS Health (CVS) , Endo International (ENDP) , Mallinckrodt (MNK) , McKesson (MCK) and Cardinal Health (CAH) .

    Reports TheStreet’s Bill Meagher: “Evercore ISI may be an outlier as its analysts anticipate that recent speeches by officials from the Food and Drug Administration, Health and Human Services and Centers for Medicare & Medicaid Services may have telegraphed the Trump administration’s willingness to move beyond loud talk and tweets into policy discussions. In those tweets and in talks with his cabinet, Trump has been critical of the pharmaceutical sector and its pricing of prescription drugs, famously saying on at least two occasions that companies are “getting away with murder.”

  • [By Lisa Levin]

    McKesson Corporation (NYSE: MCK) reported weaker-than-expected earnings for its fiscal fourth quarter.

    The company posted adjusted earnings of $3.49 per share on revenue of $51.63 billion. However, analysts were expecting earnings of $3.56 per share on revenue of $51.25 billion.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Best Buy Co., Inc. (NYSE: BBY) to report quarterly earnings at $0.74 per share on revenue of $8.73 billion before the opening bell. Best Buy shares rose 0.07 percent to $76.00 in after-hours trading.
    Analysts expect Ross Stores, Inc. (NASDAQ: ROST) to post quarterly earnings at $1.07 per share on revenue of $3.54 billion. Ross Stores shares gained 0.12 percent to $82.71 in after-hours trading.
    Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance. Williams-Sonoma shares climbed 14.88 percent to $56.50 in the after-hours trading session.
    Before the markets open, Medtronic plc (NYSE: MDT) is projected to report quarterly earnings at $1.39 per share on revenue of $8.00 billion. Medtronic shares rose 1.08 percent to $86.18 in after-hours trading.
    Analysts are expecting McKesson Corporation (NYSE: MCK) to have earned $3.56 per share on revenue of $51.25 billion in the latest quarter. McKesson will release earnings before the markets open. McKesson shares gained 0.27 percent to close at $146.83 on Wednesday.
    L Brands Inc (NYSE: LB) reported weaker-than-expected earnings for its first quarter. The company issued weak second quarter and FY18 earnings guidance. L Brands shares dropped 4.85 percent to $32.40 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Max Byerly]

    Nomura Asset Management Co. Ltd. boosted its stake in shares of McKesson Co. (NYSE:MCK) by 3.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,772 shares of the company’s stock after purchasing an additional 1,411 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in McKesson were worth $5,305,000 at the end of the most recent reporting period.

Top Small Cap Stocks To Own For 2019

Small cap social media gaming stockZynga Inc (NASDAQ: ZNGA) reportedQ2 2017 earnings after the Wednesday market close. Revenue was above guidance by $9.2 million and up 15% year-over-year to $209.2 million whilenet income was $5.1 million, better than guidance by $11.1 million and an improvement of $9.5 million year-over-year.

The earnings release noted:

In terms of our bookings performance, our teams delivered $209.2 million, beating our guidance by $4.2 million and up 20% year-over-year. This quarter represented our strongest revenue and bookings performance in four years and our best year-over-year performance since Q2 2015. The over delivery in the quarter was driven by better than expected results from our portfolio of live services

Top Small Cap Stocks To Own For 2019: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterdays 18% pop. And your core holding XBI continues to rake in the gains.

  • [By Lisa Levin]

    Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).

Top Small Cap Stocks To Own For 2019: Trevena, Inc.(TRVN)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of clinical-stage biopharma Trevena (NASDAQ:TRVN) fell nearly 12% today after it reported full-year 2016 earnings. The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.

  • [By Chris Lange]

    Trevena Inc. (NASDAQ: TRVN) reported positive results from two late-stage clinical trials that work to treat post-surgical pain. The company intends to submit these results to the FDA for a marketing approval agreement in the fourth quarter. Previously, oliceridine was approved for a breakthrough designation by the agency.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Trevena Inc (NASDAQ: TRVN) shares dropped 36 percent to $4.55 despite a positive development in Phase 3 trials. Trevena announced positive top-line results from ongoing Phase 3 trials called "APOLLO-1" and "APOLLO-2." The studies evaluated the safety of Trevena's oliceridine therapy in patients for 48 hours following bunionectomy and 24 hours following abdominoplasty.

  • [By Paul Ausick]

    Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.

Top Small Cap Stocks To Own For 2019: Baytex Energy Corp(BTE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Baytex Energy (TSE:BTE) (NYSE:BTE) had its price target raised by equities researchers at TD Securities from C$4.50 to C$5.50 in a report issued on Friday. The brokerage currently has a “hold” rating on the stock. TD Securities’ price target points to a potential downside of 0.90% from the company’s current price.

Best Bank Stocks To Watch Right Now

It’s official: Your browsing history can be sold to advertisers. President Trump on Monday signed a measure reversing rules that would have required internet providers to get consent before selling your browsing history.

The rules had not yet gone into effect, but providers now find themselves with new freedom when it comes to collecting and selling their customers’ data. What does that mean for you?

What identifying information do they have?

Internet providers already collect a lot of information that’s necessary to maintain their networks, like your location and what you’re looking at online.

Many have said they will not use “sensitive” information, like medical records, children’s data and banking details without consent. However a simple browsing history can reveal those personal details, such as symptoms you’ve Googled. There are concerns that it would be possible to identify people based on this detailed information.

According to Dane Jasper, cofounder of Sonic, an independent ISP located in California, an internet provider can infer a lot about you based just on your browsing. In addition to basics like age and gender, they might know who your friends are, if you’re a recovering alcoholic, or where you went to school. In theory, they could create an in-depth profile of you.

Best Bank Stocks To Watch Right Now: Peak Resorts, Inc.(SKIS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Peak Resorts Inc (NASDAQ: SKIS) is projected to report its quarterly earnings at $0.40 per share on revenue of $42.59 million.

    BMC Stock Holdings Inc (NASDAQ: STCK) is expected to post its quarterly earnings at $0.17 per share on revenue of $449.59 million.

Best Bank Stocks To Watch Right Now: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterdays 18% pop. And your core holding XBI continues to rake in the gains.

Best Bank Stocks To Watch Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA
    March 2017 US Challenger layoffs report 43,310 vs 36,975
    Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
    San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
    Data on money supply for the recent week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
    JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
    PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
    Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
    Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Best Bank Stocks To Watch Right Now: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

  • [By George Budwell]

    Shares of Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech developing treatments for endocrine and metabolic disorders,dropped by 30.1% last month,according toS&P Global Market Intelligence. What’s all the fuss about?

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Best Bank Stocks To Watch Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.